FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

39601011000001107: Zolgensma 20 tera vector genomes/ml (patient weight 18.6-19.0kg) solution for infusion 1 x 5.5ml + 12 x 8.3ml vials (Novartis Pharmaceuticals UK Ltd) 1 pack 1 x 5.5ml + 12 x 8.3ml vials (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 12-May 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2307771000001111 Zolgensma 20 tera vector genomes/ml (patient weight 18.6-19.0kg) solution for infusion 1 x 5.5ml + 12 x 8.3ml vials (Novartis Pharmaceuticals UK Ltd) 1 pack 1 x 5.5ml + 12 x 8.3ml vials en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2307781000001113 Zolgensma 20 tera vector genomes/ml (patient weight 18.6-19.0kg) solution for infusion 1 x 5.5ml + 12 x 8.3ml vials (Novartis Pharmaceuticals UK Ltd) 1 pack 1 x 5.5ml + 12 x 8.3ml vials (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Zolgensma 20 tera vector genomes/ml (patient weight 18.6-19.0kg) solution for infusion 1 x 5.5ml + 12 x 8.3ml vials (Novartis Pharmaceuticals UK Ltd) 1 pack 1 x 5.5ml + 12 x 8.3ml vials Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Zolgensma 20 tera vector genomes/ml (patient weight 18.6-19.0kg) solution for infusion 1 x 5.5ml + 12 x 8.3ml vials (Novartis Pharmaceuticals UK Ltd) 1 pack 1 x 5.5ml + 12 x 8.3ml vials Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Zolgensma 20 tera vector genomes/ml (patient weight 18.6-19.0kg) solution for infusion 1 x 5.5ml + 12 x 8.3ml vials (Novartis Pharmaceuticals UK Ltd) 1 pack 1 x 5.5ml + 12 x 8.3ml vials Has AMP Zolgensma 20 tera vector genomes/ml (patient weight 18.6-19.0kg) solution for infusion 1 x 5.5ml + 12 x 8.3ml vials (Novartis Pharmaceuticals UK Ltd) true Inferred relationship Existential restriction modifier
Zolgensma 20 tera vector genomes/ml (patient weight 18.6-19.0kg) solution for infusion 1 x 5.5ml + 12 x 8.3ml vials (Novartis Pharmaceuticals UK Ltd) 1 pack 1 x 5.5ml + 12 x 8.3ml vials Is a Onasemnogene abeparvovec 20 tera vector genomes/ml (patient weight 18.6-19.0kg) solution for infusion 1 x 5.5ml + 12 x 8.3ml vials 1 pack true Inferred relationship Existential restriction modifier
Zolgensma 20 tera vector genomes/ml (patient weight 18.6-19.0kg) solution for infusion 1 x 5.5ml + 12 x 8.3ml vials (Novartis Pharmaceuticals UK Ltd) 1 pack 1 x 5.5ml + 12 x 8.3ml vials Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Zolgensma 20 tera vector genomes/ml (patient weight 18.6-19.0kg) solution for infusion 1 x 5.5ml + 12 x 8.3ml vials (Novartis Pharmaceuticals UK Ltd) 1 pack 1 x 5.5ml + 12 x 8.3ml vials Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Zolgensma 20 tera vector genomes/ml (patient weight 18.6-19.0kg) solution for infusion 1 x 5.5ml + 12 x 8.3ml vials (Novartis Pharmaceuticals UK Ltd) 1 pack 1 x 5.5ml + 12 x 8.3ml vials Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Zolgensma 20 tera vector genomes/ml (patient weight 18.6-19.0kg) solution for infusion 1 x 5.5ml + 12 x 8.3ml vials (Novartis Pharmaceuticals UK Ltd) 1 pack 1 x 5.5ml + 12 x 8.3ml vials Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Zolgensma 20 tera vector genomes/ml (patient weight 18.6-19.0kg) solution for infusion 1 x 5.5ml + 12 x 8.3ml vials (Novartis Pharmaceuticals UK Ltd) 1 pack 1 x 5.5ml + 12 x 8.3ml vials Has specific active ingredient Onasemnogene abeparvovec true Inferred relationship Existential restriction modifier
Zolgensma 20 tera vector genomes/ml (patient weight 18.6-19.0kg) solution for infusion 1 x 5.5ml + 12 x 8.3ml vials (Novartis Pharmaceuticals UK Ltd) 1 pack 1 x 5.5ml + 12 x 8.3ml vials VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Zolgensma 20 tera vector genomes/ml (patient weight 18.6-19.0kg) solution for infusion 1 x 5.5ml + 12 x 8.3ml vials (Novartis Pharmaceuticals UK Ltd) 1 pack 1 x 5.5ml + 12 x 8.3ml vials Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Zolgensma 20 tera vector genomes/ml (patient weight 18.6-19.0kg) solution for infusion 1 x 5.5ml + 12 x 8.3ml vials (Novartis Pharmaceuticals UK Ltd) 1 pack 1 x 5.5ml + 12 x 8.3ml vials VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Zolgensma 20 tera vector genomes/ml (patient weight 18.6-19.0kg) solution for infusion 1 x 5.5ml + 12 x 8.3ml vials (Novartis Pharmaceuticals UK Ltd) 1 pack 1 x 5.5ml + 12 x 8.3ml vials Has dispensed dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start